SeouLinBioscience Company Overview

  • Year Founded
  • 1994

Year Founded

  • Status
  • Public

  • Employees
  • 109

Employees

  • Stock Symbol
  • 038070

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $2.63
  • (As of Friday Closing)

SeouLinBioscience Company General Information

Description

SeouLinBioscience Co Ltd is a South Korean company operating in biotechnology industry. The company focuses on bio research and production, manufacturing, diagnostics, and healthcare. It also provides hygiene/sterilization solutions. The company's business segments include: Bio Industry total solutions business, Hygiene/Disinfection Solutions, and healthcare.

Contact Information

Formerly Known As
Seoulin Science
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 4Floor, A-dong, Korea Bio Park
  • 694-1, Sampyeong-dong, Bundang-gu
  • Seongnam-si, Gyeonggi-do 463-400
  • South Korea
+82
Primary Industry
Other Devices and Supplies
Stock Exchange
KRX
Vertical(s)
Corporate Office
  • 4Floor, A-dong, Korea Bio Park
  • 694-1, Sampyeong-dong, Bundang-gu
  • Seongnam-si, Gyeonggi-do 463-400
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SeouLinBioscience Company Stock Performance

As of 20-Nov-2026, SeouLinBioscience Company’s stock price is $2.63. Its current market cap is $23.3M with 8.83M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.63 $2.63 $2.40 - $5.12 $23.3M 8.83M 24.5K $0.07

SeouLinBioscience Company Financials Summary

As of 30-Jun-2026, SeouLinBioscience Company has a trailing 12-month revenue of $57.3M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 11,295 26,225 26,541 36,139
Revenue 57,306 54,170 55,268 68,507
EBITDA 1,762 1,379 3,118 (161)
Net Income 632 514 2,136 (90)
Total Assets 74,686 82,498 68,925 88,540
Total Debt 8,606 8,041 2,498 5,210
Public Fundamental Data provided by Morningstar, Inc. disclaimer

SeouLinBioscience Company Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore SeouLinBioscience Company‘s full profile, request access.

Request a free trial

SeouLinBioscience Company Patents

SeouLinBioscience Company Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2015007294-A1 Chimera silver nanocluster probes for mirna detection Inactive 19-Jul-2013
WO-2015007293-A1 Stem-loop silver nanocluster probes for mirna detection Inactive 19-Jul-2013
US-20150225781-A1 Silver nanocluster probe and target polynucleotide detection method using same, and silver nanocluster probe design method Active 22-Aug-2012
US-9777313-B2 Silver nanocluster probe and target polynucleotide detection method using same, and silver nanocluster probe design method Active 22-Aug-2012
WO-2014030778-A1 Silver nanocluster probe and target polynucleotide detection method using same, and silver nanocluster probe design method Inactive 22-Aug-2012 C12Q1/6816
To view SeouLinBioscience Company’s complete patent history, request access »

SeouLinBioscience Company Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SeouLinBioscience Company Investments (1)

SeouLinBioscience Company’s most recent deal was a Early Stage VC with Bipeco. The deal was made on 02-Oct-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Bipeco 02-Oct-2022 Early Stage VC Food Products
To view SeouLinBioscience Company’s complete investments history, request access »

SeouLinBioscience Company ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view SeouLinBioscience Company’s complete esg history, request access »

SeouLinBioscience Company FAQs

  • When was SeouLinBioscience Company founded?

    SeouLinBioscience Company was founded in 1994.

  • Where is SeouLinBioscience Company headquartered?

    SeouLinBioscience Company is headquartered in Seongnam-si, South Korea.

  • What is the size of SeouLinBioscience Company?

    SeouLinBioscience Company has 109 total employees.

  • What industry is SeouLinBioscience Company in?

    SeouLinBioscience Company’s primary industry is Other Devices and Supplies.

  • Is SeouLinBioscience Company a private or public company?

    SeouLinBioscience Company is a Public company.

  • What is SeouLinBioscience Company’s stock symbol?

    The ticker symbol for SeouLinBioscience Company is 038070.

  • What is the current stock price of SeouLinBioscience Company?

    As of 20-Nov-2026 the stock price of SeouLinBioscience Company is $2.63.

  • What is the current market cap of SeouLinBioscience Company?

    The current market capitalization of SeouLinBioscience Company is $23.3M.

  • What is SeouLinBioscience Company’s current revenue?

    The trailing twelve month revenue for SeouLinBioscience Company is $57.3M.

  • What is SeouLinBioscience Company’s annual earnings per share (EPS)?

    SeouLinBioscience Company’s EPS for 12 months was $0.07.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process